Factoring nonviral gene therapy into a cure for hemophilia A
{{output}}
Gene therapy for hemophilia A has fallen short of success despite several clinical trials conducted over the past decade. Challenges to its success include vector immunogenicity, insufficient transgene expression levels of Factor VIII, and inhibitor antibody f... ...
